MedChem: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MedChem
Largest movements
- Cash +€108,313
up €108,313 (+33.9%), from €319,785 to €428,098
mainly Net result for the year (+€158,106) and Depreciation (+€6,580)
- Deferred charges and accrued income +€17,948
up €17,948 (+86.4%), from €20,763 to €38,711
- Reserves +€158,000
up €158,000 (+35.0%), from €451,000 to €609,000
- Provisions -€26,982
down €26,982 (-9.1%), from €296,150 to €269,168
- Gross operating margin +€27,230
up €27,230 (+13.2%), from €206,751 to €233,981
- Taxes +€9,795
up €9,795 (+14.9%), from €65,723 to €75,517
- Financial income +€3,060
up €3,060 (+29.8%), from €10,284 to €13,344
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €797,581 | €917,262 | +€119,681 | +15.0% |
| Fixed assets | 21/28 | €32,593 | €26,013 | -€6,580 | -20.2% |
| Intangible fixed assets | 21 | €24,160 | €19,797 | -€4,363 | -18.1% |
| Tangible fixed assets | 22/27 | €8,433 | €6,216 | -€2,217 | -26.3% |
| Plant, machinery and equipment | 23 | €3,930 | €3,011 | -€920 | -23.4% |
| Furniture and vehicles | 24 | €4,503 | €3,205 | -€1,298 | -28.8% |
| Current assets | 29/58 | €764,988 | €891,249 | +€126,261 | +16.5% |
| Amounts receivable within one year | 40/41 | €0 | - | = | |
| Trade receivables | 40 | €0 | - | = | |
| Current investments | 50/53 | €424,440 | €424,440 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €319,785 | €428,098 | +€108,313 | +33.9% |
| Deferred charges and accrued income | 490/1 | €20,763 | €38,711 | +€17,948 | +86.4% |
| Total equity and liabilities | 10/49 | €797,581 | €917,262 | +€119,681 | +15.0% |
| Equity | 10/15 | €478,578 | €636,684 | +€158,106 | +33.0% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €451,000 | €609,000 | +€158,000 | +35.0% |
| Distributable reserves | 133 | €451,000 | €609,000 | +€158,000 | +35.0% |
| Profit (loss) carried forward | 14 | €15,178 | €15,284 | +€106 | +0.7% |
| Provisions and deferred taxes | 16 | €296,150 | €269,168 | -€26,982 | -9.1% |
| Provisions for liabilities and charges | 160/5 | €296,150 | €269,168 | -€26,982 | -9.1% |
| Pensions and similar obligations | 160 | €296,150 | €269,168 | -€26,982 | -9.1% |
| Amounts payable | 17/49 | €22,852 | €11,410 | -€11,443 | -50.1% |
| Amounts payable within one year | 42/48 | €22,852 | €11,410 | -€11,443 | -50.1% |
| Trade debts | 44 | €2,969 | €0 | -€2,969 | -100% |
| Suppliers | 440/4 | €2,969 | €0 | -€2,969 | -100% |
| Taxes, remuneration and social security | 45 | €14,727 | €6,633 | -€8,093 | -55.0% |
| Taxes | 450/3 | €14,727 | €6,633 | -€8,093 | -55.0% |
| Other amounts payable | 47/48 | €5,157 | €4,777 | -€380 | -7.4% |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,546 | €6,580 | +€35 | +0.5% |
| Other operating charges | 640/8 | €762 | €781 | +€19 | +2.5% |
| Gross operating margin | 9900 | €206,751 | €233,981 | +€27,230 | +13.2% |
| Operating profit (loss) | 9901 | €199,443 | €226,620 | +€27,177 | +13.6% |
| Financial income | 75/76B | €10,284 | €13,344 | +€3,060 | +29.8% |
| Recurring financial income | 75 | €10,284 | €13,344 | +€3,060 | +29.8% |
| Financial charges | 65/66B | €6,933 | €6,341 | -€592 | -8.5% |
| Recurring financial charges | 65 | €6,933 | €6,341 | -€592 | -8.5% |
| Profit (loss) for the period before taxes | 9903 | €202,794 | €233,623 | +€30,829 | +15.2% |
| Income taxes | 67/77 | €65,723 | €75,517 | +€9,795 | +14.9% |
| Profit (loss) for the period | 9904 | €137,071 | €158,106 | +€21,034 | +15.3% |
| Profit (loss) for the period to be appropriated | 9905 | €137,071 | €158,106 | +€21,034 | +15.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.